Immunoguide® Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma.
The drug Tocilizumab (trade name Actemra®) is a humanized monoclonal antibody (mAb) that specifically targets both soluble interleukin-6 receptor (sIL-6R) and membrane bound interleukin-6 receptor (mIL-6R) with a high affinity, thereby preventing pro-inflammatory effects of IL-6.
The ImmunoGuide Antibody to Tocilizumab ELISA Kit can be efficiently used for monitoring Anti-Tocilizumab antibodies during therapy and offers a tool for decision on possible preventive measures to reduce Anti-Tocilizumab antibodies. For research use only, not for use in diagnostic procedures.
- Assay Description:
- 1 hour incubation (RT) + 1 hour (RT) + 15 min. (RT) = 2 hours, 15 min. total incubation time
- Catalog number:
- TM09022
- configuration:
- 96 Determinations, 12x8 removable strips
- controls:
- Positive control
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- For research use only, not for use in diagnostic procedures
- MSDS:
- Available upon request
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Other names:
- Atlizumab
- Protocol:
- Sample types:
- Serum and plasma
- Sample volume:
- 10 µL
- Standards:
- 5 Standards, ready to use
- Standard range:
- 0 / 3 - 100 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 4 ng/mL
- Species:
- Human
- Products related:
- Tocilizumab (Actemra®) (mAb-based) ELISA
- Additional info:
